Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2013.272 | A single-arm phase II study to determine the efficacy of preemptive local ablative therapy to residual metabolic active oligo-metastases in those EGFR mutation positive non-small cell lung cancer patients who have achieved a good partial response with first-line EGFR TKI (ATOM) | Dr. LAM Kwok Chi |
| 2013.269 | A RANDOMIZED, OPEN-LABEL, MULTI-CENTRE STUDY TO EVALUATE PATIENT PREFERENCE WITH SUBCUTANEOUS ADMINISTRATION OF RITUXIMAB VERSUS INTRAVENOUS RITUXIMAB IN PREVIOUSLY UNTREATED PATIENTS WITH CD20+ DIFFUSE LARGE B-CELL LYMPHOMA OR CD20+ FOLLICULAR NON-HODGKIN’S LYMPHOMA GRADES 1, 2 OR 3A | Dr. WONG Raymond Siu Ming |
| 2013.264 | A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients | Prof. Chan Lik Yuen Henry |
| 2013.259 | A prospective, randomized study of high-density electroencephalography for refractory Chinese epilepsy patients | Prof. LEUNG Howan |
| 2013.258 | Self-Control Interventions for Children with Autism Spectrum Disorders: Computerized Training vs Chinese Mind-Body Exercise | Prof. Chan Sui-yin, Agnes |
| 2013.256 | Phase 2 study on safety and efficacy of irreversible electroporation for inoperable hepatic and pancreatic malignancy | Prof. YU Simon |
| 2013.244 | MADIT ASIA CARDIAC RESYNCHRONIZATION TRIAL | Prof Yu Cheuk-Man |
| 2013.237 | A Multicenter, Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-Line Treatment of Subjects With Unresectable Hepatocellular Carcinoma | Dr. CHAN Stephen L. |
| 2013.224 | A randomized comparison between white light endoscopy (WLE) and bright narrow band imaging (NBI) in subjects undergoing upper gastrointestinal endoscopy | Prof Chiu Wai Yan Philip |
| 2013.223 | A MULTICENTRE STUDY FOR THE EVALUATION OF EFFICACY AND SAFETY OF BUPRENORPHINE TRANSDERMAL PATCH (NORSPANｮ OR SOVENORｮ TRANSDERMAL PATCH)IN PATIENTS WITH NON-MALIGNANT PAIN OF MODERATE TO SEVERE INTENSITY DUE TO OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, LOWER BACK PAIN AND JOINT / MUSCLE PAIN, WHEN AN OPIOID IS NECESSARY FOR OBTAINING ADEQUATE ANALGESIA | Dr. CHAN Simon KC |
| 2013.219 | High Risk Neuroblastoma Study 1.5 of SIOP-Europe (SIOPEN) | Dr. Lee Vincent |
| 2013.213 | A 52-week treatment, multi-center, randomized, double-blind, double dummy, parallel-group, active controlled study to compare the effect of QVA149 (indacaterol maleate / glycopyrronium bromide) with salmeterol/fluticasone on the rate of exacerbations in subjects with moderate to very severe COPD | Prof. HUI David Shu Cheong |
| 2013.212 | Impact of Brown Bag Review on Drug-Related Problems in a Local Hospital Setting: A Randomized Controlled Study | Ms Lau Cho Kwan |
| 2013.210 | Intramuscular olanzapine versus haloperidol or midazolam for the management of acute agitation in the emergency department – a multicentre randomised clinical trial. | Prof. GRAHAM Colin |
| 2013.209 | Prostate artery embolization for symptomatic benign prostatic hyperplasia | Prof. YU Simon C.H. |
| 2013.208 | Evaluation of Magnetorhelogical-damper Based Prostheses in Locomotion Assistance | Prof Liao Wei-Hsin |
| 2013.201 | Randomized trial on intraveous antibiotics with adjunctive lavage for severe peritoneal-dialysis related peritonitis | Dr. WONG Siu Man |
| 2013.200 | Changes in Central Esophageal Sensitivity in Mediating Symptom Response in Non-erosive Reflux Disease | Dr. Mak Arthur Dun-Ping |
| 2013.195 | Randomized controlled trial on recovery-oriented coaching intervention for patients with early psychosis | Dr Wong Yip Chau |
| 2013.192 | Chinese herbal medicine (MaZiRenWan) for functional constipation: a prospective, double-blinded, double-dummy, randomized controlled study | Prof. Wu Justin Che-Yuen |
| 2013.180 | Effects of Integrated Attention training on cognition and everyday function for healthy older Chinese adults with subjective cognitive complaints but no clinical dementia | Dr Ma Suk Ling |
| 2013.179 | Effects of Antenatal Vitamin D Supplementationation on Postpartum Depression: A Randomized, Controlled, Double-blinded Clinical Trial among Chinese Women in Hong Kong | Professor Wong Carmen |
| 2013.175 | Multi-centre, randomised, double-blind and placebo-controlled clinical trial of vitamin D treatment for childhood eczema | Professor Hon Kam-Lun Ellis |
| 2013.168 | Impact of a Professional Development Program on the Student Learning Outcome and Teacher Self-Efficacy toward Teaching Games for Understanding | Professor HA Sau-ching Amy |
| 2013.167 | A Multicenter, Open-Label Phase 2 Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung | Prof. MOK Tony Shu Kam |
| 2013.166 | Efficacy and safety of agomelatine (25 mg/day with blinded potential adjustment to 50 mg/day) for 12 weeks in non-depressed out-patients with Generalized Anxiety Disorder. A 12-week randomised, double-blind, versus venlafaxine (75 mg/day with blinded potential adjustment up to 225 mg/day), 2-arm parallel groups, international multicenter study. | Prof. WING Yun Kwok |
| 2013.160 | Cultivation of self-compassion and mindfulness through mobile applications for the promotion of mental well-being: a randomized controlled trial | Prof. MAK Winnie Wing Sze |
| 2013.159 | A phase II trial of neoadjuvant imatinib for large gastric GIST in Asia | Professor Ng Enders Kwok Wai |
| 2013.156 | A multi-centre 3-year follow-up study to assess the durability of sustained virologic response in Alisporivir-treated chronic Hepatitis C patients | Prof. Chan Henry Lik-Yuen |
| 2013.154 | A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF ALEGLITAZAR MONOTHERAPY COMPARED WITH PLACEBO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2D) WHO ARE DRUG-NA_VE TO ANTIHYPERGLYCEMIC THERAPY | Dr. Tsang Chiu Chi |
| 2013.153 | A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF ALEGLITAZAR MONOTHERAPY COMPARED WITH PLACEBO IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2D) WHO ARE DRUG-NA_VE TO ANTIHYPERGLYCEMIC THERAPY | Prof. Kong Pik Shan |
| 2013.152 | A randomized controlled trial of a tailored intervention targeted smoking type 2 diabetic patients to promote smoking cessation and improve glycamic control | Dr. Ozaki Risa |
| 2013.151 | A randomized control trial for a structured exercise promotion program for stage I to Stage III breast cancer patients during adjuvant chemotherapy and radiotherapy to evaluate its efficacy by physical activity level, quality of life, fatigue level and shoulder range of motion. | Chan Sau Man Mandy |
| 2013.141 | Comparison in treatment effects on tennis elbow between using acupuncture and extracorporeal shockwave, randomized controlled trial study design, single-blinded, measured by pain intensity, maximal grip strength and functional impairment | Miss Ng Yin Ling |
| 2013.130 | The effectiveness of extracorporeal shockwave therapy De Quervain's tenosynovitis, non-randomized controlled study,measured by pain intensity, maximal grip strength and Ulnar deviation | Ms Ho Shuk Ling |
| 2013.123 | A cluster randomized controlled trial of an integrated physical cognitive exercise intervention on cognitive and everyday function in older adults living with Mild Alzheimer's disease | Professor Lam Linda Chiu-wa |
| 2013.119 | Effect of natural S-equol on blood pressure and vascular function - a six-month randomized, double-blind and placebo-controlled trial among equol non-producers of postmenopausal women with prehypertension or untreated stage 1 hypertension | Dr. Liu Zhaomin |
| 2013.117 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Dr. Hui Aric Josun |
| 2013.115 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Prof Chan Lik Yuen Henry |
| 2013.105 | A randomized controlled trial on the efficacy of tenofovir disoproxil fumarate (TDF)-switch therapy in chronic hepatitis B patients with incomplete response to entecavir | Dr. WONG Grace Lai Hung |
| 2013.098 | A Multicenter Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr Ozaki Risa |
| 2013.097 | Application of Low-Magnitude High-Frequency Vibration to Retard the Progress of Sarcopenia | Professor Cheung Wing Hoi |
| 2013.094 | A randomized controlled trial to investigate the independent and joint effects of diet and exercise on endogenous estrogen concentrations among overweight/obese postmenopausal Chinese women in Hong Kong | Prof. Su Xuefen |
| 2013.089 | ARCHER 1050: A RANDOMIZED, OPEN-LABEL, PHASE 3, EFFICACY AND SAFETY STUDY OF DACOMITINIB (PF-00299804) VERSUS GEFITINIB FOR THE FIRST LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN SUBJECTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) ACTIVATING MUTATION(S) | Prof. MOK Tony Shu Kam |
| 2013.088 | A Phase 1/2, Dose-escalation, Open-label, Non-comparative Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Advanced Hepatocellular Carcinoma Subjects with or without Chronic Viral Hepatitis; and a Randomized, Open-label Study of Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Subjects who are Naive to Systemic Therapy | Prof. YEO Winnie |
| 2013.081 | A Randomized, Single-blinded, Controlled Trial to Investigate the Efficacy of Low-Magnitude High-Frequency Vibration Treatment on Early Stage Osteoarthritic Knee (VTOAK) | Professor Leung Kwok Sui |
| 2013.073 | The Impact of Breakfast Glycemic Index on Appetite Control in Primary School Teachers in Hong Kong: A Randomized Cross-over Design | Prof. Wong Heung-Sang Stephen |
| 2013.071 | A Multicenter, Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 145 on LDL-C in Subjects With Severe Familial Hypercholesterolemia | Dr. LUK Andrea On Yan |
| 2013.070 | A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr. LUK Andrea On Yan |
| 2013.069 | A 2-Part, Phase 2/3 Study to Assess the Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia Part A - Open-label, Single-arm, Multicenter Pilot Study to Evaluate Safety, Tolerability, and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia Part B - Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate Safety, Tolerability and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia | Professor Tomlinson Brian |
Page 227 of 263.